Latest BCAB reports update at 2024-03-26: 20232022
BioAtla logo
BioAtla BCAB
$ 3.25 2.85%

BioAtla Financial Statements 2011-2024 | BCAB

Annual Financial Statements BioAtla

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

144 M 98.5 M 224 M 949 M - - - - - - - - -

Shares

47.8 M 38.9 M 34.6 M 21.6 M - - - - - - - - -

Historical Prices

3.01 2.53 6.48 53.1 - - - - - - - - -

Net Income

-123 M -106 M -95.4 M -35.9 M -29.8 M -29 M - - - - - - -

Revenue

- - 300 K 429 K 5.2 M 10.6 M - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - 429 - - - - - - - - -

Operating Income

-130 M -108 M -96.4 M -30.1 M -28.3 M - - - - - - - -

Interest Expense

6.22 M 1.66 M 3 K 1.39 M 1.63 M - - - - - - - -

EBITDA

-128 M -107 M -95.1 M -29.1 M -27.4 M -27.4 M - - - - - - -

Operating Expenses

130 M 108 M 96.7 M 30.5 M 33.5 M 38.9 M - - - - - - -

General and Administrative Expenses

26 M 28.8 M 38.4 M 10.6 M 7.55 M 12.6 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement BioAtla

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

47.8 M 47.7 M 47.6 M 46.3 M 37.5 M 37.4 M 37.3 M 35.8 M 33.9 M 33.7 M 33.6 M 32.2 M 80.9 M 32.2 M 32.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-33.3 M -35.8 M -27.5 M - -25.8 M -28.9 M -24.3 M - -22.9 M -30.4 M -18.7 M - -11.6 M -6.22 M -1.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - 300 K 300 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-35 M -37.2 M -28.9 M - -26.2 M -29.1 M -24.3 M - -23.7 M -30.5 M -18.8 M - -8.02 M -4.52 M -1.11 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

1.7 M 1.45 M 1.47 M - 400 K 149 K 92 K - 3 K 1 K 2 K - 86 K 754 K 547 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -28.6 M - -25.3 M -28.5 M -24 M - -22.7 M -29.8 M -18.5 M - -7.3 M -4.09 M -893 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

35 M 37.2 M 28.9 M - 26.2 M 29.1 M 24.3 M - 23.7 M 30.7 M 18.8 M - 8.16 M 4.71 M 1.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

6.62 M 6.24 M 7.23 M - 6.34 M 8.34 M 7.42 M - 7.14 M 15.9 M 8.37 M - 3.3 M 1.79 M 463 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency